[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370720-105":59,"doc-detail-370720-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pcna-in-pan-cancer-a-prognostic-biomarker-unveiled-through-a-data-driven-multidimensional-analysis-of-transcriptomics-immunity-and-functional-profiling","PCNA in Pan-Cancer - A Prognostic Biomarker Unveiled Through a Data-Driven, Multidimensional Analysis of Transcriptomics, Immunity, and Functional Profiling","","Proliferating cell nuclear antigen (PCNA) regulates DNA metabolism and genetic integrity, driving processes such as DNA damage responses, cell-cycle progression, and transcriptional control. Aberrant PCNA patterns appear across disease phenotypes, including neoplastic proliferation, chromatin disruption, genomic instability, and impaired repair. To clarify pan-cancer relevance, the study integrates multiomics from public databases to link PCNA expression with immunity, survival, genetics, functional traits, and drug sensitivity. Results show altered PCNA mRNA across cancers, amplification as the dominant genetic change, immune-associated expression differences, and increased sensitivity to drugs including Navitoclax and Ciclopirox.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pcna-in-pan-cancer-a-prognostic-biomarker-unveiled-through-a-data-driven-multidimensional-analysis-of-transcriptomics-immunity-and-functional-profiling/370720/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pcna-in-pan-cancer-a-prognostic-biomarker-unveiled-through-a-data-driven-multidimensional-analysis-of-transcriptomics-immunity-and-functional-profiling/370720.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What biological role does PCNA play in the cell processes discussed in the study?","Question",{"text":113,"@type":114},"PCNA is presented as a central regulator of DNA metabolism and genetic integrity, coordinating DNA damage responses, cell-cycle progression, transcriptional regulation, and replication-linked repair activities.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the analysis link PCNA expression to cancer outcomes across multiple cancer types?",{"text":118,"@type":114},"The study uses publicly available databases to associate PCNA mRNA levels with immunological features, survival patterns, genetic alterations, functional characteristics, and drug sensitivity across cancers.",{"name":120,"@type":111,"acceptedAnswer":121},"Which types of genetic and immune-related changes were reported for PCNA in cancers?",{"text":122,"@type":114},"Amplification was identified as the predominant genetic alteration of PCNA. In several tumors, higher PCNA expression correlated with differences in tumor-infiltrating lymphocytes and immune-inhibitor and chemokine profiles.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370720,1790863758,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","This article is licensed under CC-BY 4.0   \n[http://pubs.acs.org/journal/acsodf](http://pubs.acs.org/journal/acsodf)  Article   \nPCNA in Pan-Cancer: A Prognostic Biomarker Unveiled Through a Data-Driven, Multidimensional Analysis of Transcriptomics, Immunity, and Functional Profiling  \nDepanshi Pandit, Ravindranath Bilachi Sanganabasappa, * Amardeep Dhillon, and Sanjiban Chakrabarty  \n Cite This: ACS Omega 2025, 10, 28311−28326  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Proliferating cell nuclear antigen (PCNA) is a central regulator of numerous cellular processes impacting DNA metabolism and genetic integrity, including DNA damage, cell cycle progression, and transcriptional regulation. PCNA aberrations manifest in different disease phenotypes, including neoplastic proliferation, chromatin disassembly, genomic instability, and impaired DNA repair. Although the role of PCNA in control of DNA homeostasis has been extensively studied in some cancers, itspan-cancer relevance in tumorigenesis, immune interactions, and therapeutic resistance remains underexplored. Here, we undertook a comprehensive analysis of publicly available databases to assess the relationship between PCNA expression and the immunological, survival, genetic, functional, and drug sensitivity profiles across multiple cancer types. PCNA mRNA levels were altered in across cancers and associated with altered cancer signaling networks constituting Wnt, Hippo, and mTOR pathways. Increased transcript levels were associated with poor overall survival in some cancers, including ACC, CESC, LGG, and THYM. Amplification was the predominant genetic alteration of PCNA in multiple tumors. In several tumors, upregulation of PCNA was linked with differences in tumor-infiltrating lymphocytes, and specific immune-inhibitors, and chemokines. Moreover, elevated PCNA expression was linked with increased sensitivity to several drugs, particularly to Navitoclax, NPK76-II-72-1, and Ciclopirox across cancers. Our study orients the first comprehensive pan-cancer analysis of PCNA, uncovering its prognostic significance and altered expression across various cancers through multiomics data. Unlike previous studies, tumor-specific genetic alterations, such as amplification and hypomethylation, and the paradoxical immune microenvironment linked to PCNA were explored, suggesting potential immune evasion mechanisms. Additionally, new therapeutic avenues reveal PCNA’s relationship with drug sensitivity to agents like Navitoclax and Ciclopirox, providing invaluable insights for pharmacological interventions.  \n1. INTRODUCTION  \nCancer encompasses a spectrum of disease phenotypes characterized by genetic variability and diverse mechanisms orchestrating tumor development, progression, and therapy resistance. The heterogeneity of cancers poses a major roadblock in the development of universal biomarkers and treatment methods. Thus, identifying therapeutic targets critical across multiple cancer types could transform early diagnosis and treatment paradigms, providing unified approach to combat this multifaceted disease.  \nProliferating cell nuclear antigen (PCNA) is regarded as “the maestro of the replication fork”1 because it regulates DNA synthesis and directs repair components to damage sites within the replication fork. PCNA is a homotrimer with a toroidal structure that encircles DNA as a sliding clamp without dissociating, displaying quasi 6-fold symmetry which is critical for DNA replication and repair.2−4 It serves as a key scaffold in DNA replication and repair and assures the processivity factor  \nof DNA polymerase δ during replication.5 PCNA and its myriad of binding partners participate in DNA synthesis, Okazaki fragment maturation, replication-coupled nucleosome assembly, chromatin assembly, DNA repair including nucleotide excision repair, mismatch repair","cbCairfz1uraqD4p","https://ap.wps.com/l/cbCairfz1uraqD4p","pdf",9807090,16,"English","# Abstract\n# Introduction","[{\"question\":\"What biological role does PCNA play in the cell processes discussed in the study?\",\"answer\":\"PCNA is presented as a central regulator of DNA metabolism and genetic integrity, coordinating DNA damage responses, cell-cycle progression, transcriptional regulation, and replication-linked repair activities.\"},{\"question\":\"How does the analysis link PCNA expression to cancer outcomes across multiple cancer types?\",\"answer\":\"The study uses publicly available databases to associate PCNA mRNA levels with immunological features, survival patterns, genetic alterations, functional characteristics, and drug sensitivity across cancers.\"},{\"question\":\"Which types of genetic and immune-related changes were reported for PCNA in cancers?\",\"answer\":\"Amplification was identified as the predominant genetic alteration of PCNA. In several tumors, higher PCNA expression correlated with differences in tumor-infiltrating lymphocytes and immune-inhibitor and chemokine profiles.\"}]","PCNA in Pan-Cancer - A Prognostic Biomarker Unveiled Through a Data-Driven, Multidimensional Analysis of Transcriptomics, Immunity, and Functional Profiling | PDF",1790190058,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95402afcb534d459703e86b68e687df0.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a5ba435f65a7047274b0b20c5f0e1e1.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b0d5768d04b8a0b63cf55cd9f3732c2a.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0cbe7b132d9c3c8634c923e92a34c279.webp",980,1292]